Physician profile
Michael Ross
NPI 1023407814
$3,091.77
in general payments reported to CMS, 2019-2025
10 companies · $861 in 2025
The $861 reported for 2025 was more than what 88% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $274 · 2021: $248 · 2022: $529 · 2023: $1,095 · 2024: $85.19 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Gift: $96.23 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.84 |
| Gift | $96.23 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,088.72 | 2020-2025 | Empower-Metal, Master Series, Radiance |
| Align Technology, INC. | $660.87 | 2024-2025 | Invisalign |
| Ormco Corporation | $540.10 | 2022-2023 | Spark, Miniendo II, Damon Clear |
| Nobel Biocare USA | $391.88 | 2023 | Nobelactive |
| Envista Holdings Corporation | $142.94 | 2024-2025 | Spark, Tma |
| Henry Schein, INC. | $86.62 | 2022 | |
| Gc America INC. | $81.92 | 2020-2021 | |
| Voco America INC. | $62.99 | 2021 | |
| Philips North America LLC | $26.25 | 2021 | |
| Ultradent Products INC | $9.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.